Aker Biomarine AS (OL:AKBM) — Stock Price
Aker Biomarine AS (OL:AKBM) is currently trading at Nkr115.60 NOK, down 0.17% today. Over the past 52 weeks, shares have ranged between Nkr76.50 and Nkr115.80. This page tracks Aker Biomarine AS's live share price on the OL exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Aker Biomarine AS worth.
Aker Biomarine AS (AKBM) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Aker Biomarine AS's daily closing share price and trading volume on the OL exchange over the past year, giving a clear view of recent price momentum and liquidity.
Aker Biomarine AS Income Statement — Revenue, Profit & Earnings by Year
Aker Biomarine AS's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | Nkr199.00 Million | Nkr335.30 Million | Nkr277.20 Million | Nkr262.06 Million | Nkr288.59 Million |
| Cost of Revenue | Nkr120.60 Million | Nkr222.40 Million | Nkr162.40 Million | Nkr174.00 Million | Nkr179.01 Million |
| Gross Profit | Nkr78.40 Million | Nkr112.90 Million | Nkr114.80 Million | Nkr88.06 Million | Nkr109.58 Million |
| Research & Development | Nkr1.00 Million | Nkr1.10 Million | Nkr4.00 Million | Nkr3.00 Million | Nkr3.90 Million |
| SG&A | Nkr68.00 Million | Nkr90.10 Million | Nkr82.50 Million | Nkr82.75 Million | Nkr83.90 Million |
| Total Operating Expenses | Nkr206.60 Million | Nkr206.60 Million | Nkr258.00 Million | Nkr278.70 Million | Nkr283.79 Million |
| Operating Income | Nkr-4.20 Million | Nkr5.30 Million | Nkr22.10 Million | Nkr-13.67 Million | Nkr7.00 Million |
| EBITDA | — | — | — | — | — |
| EBIT | Nkr-4.20 Million | Nkr5.30 Million | Nkr22.10 Million | Nkr-13.67 Million | Nkr7.00 Million |
| Interest Expense | Nkr2.50 Million | Nkr3.90 Million | Nkr20.30 Million | Nkr13.70 Million | Nkr18.74 Million |
| Income Before Tax | Nkr-12.10 Million | Nkr-33.90 Million | Nkr12.20 Million | Nkr-7.40 Million | Nkr688.00K |
| Income Tax Expense | — | — | — | — | — |
| Net Income | Nkr182.40 Million | Nkr-8.90 Million | Nkr10.00 Million | Nkr-8.01 Million | Nkr-5.46 Million |
Aker Biomarine AS Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Aker Biomarine AS's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | Nkr387.40 Million | Nkr827.10 Million | Nkr824.50 Million | Nkr757.49 Million | Nkr700.43 Million |
| Total Current Assets | Nkr201.70 Million | Nkr290.20 Million | Nkr298.70 Million | Nkr239.54 Million | Nkr223.12 Million |
| Cash & Equivalents | Nkr15.00 Million | Nkr25.30 Million | Nkr22.30 Million | Nkr9.15 Million | Nkr9.09 Million |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | Nkr47.30 Million | Nkr57.60 Million | Nkr60.00 Million | Nkr50.30 Million | Nkr53.72 Million |
| Inventory | Nkr96.30 Million | Nkr183.70 Million | Nkr182.70 Million | Nkr138.22 Million | Nkr114.56 Million |
| Property, Plant & Equipment | Nkr51.60 Million | Nkr350.60 Million | Nkr343.10 Million | Nkr339.11 Million | Nkr279.70 Million |
| Goodwill | Nkr62.60 Million | Nkr94.60 Million | Nkr94.60 Million | Nkr94.61 Million | Nkr94.61 Million |
| Total Liabilities | Nkr213.50 Million | Nkr460.60 Million | Nkr445.80 Million | Nkr387.12 Million | Nkr327.26 Million |
| Total Current Liabilities | Nkr53.10 Million | Nkr112.90 Million | Nkr104.70 Million | Nkr77.32 Million | Nkr70.94 Million |
| Long-term Debt | Nkr138.70 Million | Nkr339.10 Million | Nkr333.60 Million | Nkr286.65 Million | Nkr204.34 Million |
| Net Debt | Nkr130.00 Million | Nkr357.80 Million | Nkr349.60 Million | Nkr303.80 Million | Nkr219.93 Million |
| Total Stockholder Equity | Nkr173.50 Million | Nkr366.60 Million | Nkr378.70 Million | Nkr370.37 Million | Nkr373.17 Million |
| Retained Earnings | Nkr-396.30 Million | Nkr-203.30 Million | Nkr-194.40 Million | Nkr-204.39 Million | Nkr-196.38 Million |
Aker Biomarine AS Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Aker Biomarine AS generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | Nkr12.20 Million | Nkr47.40 Million | Nkr15.10 Million | Nkr729.00K | Nkr-51.04 Million |
| Capital Expenditures | Nkr23.10 Million | Nkr49.30 Million | Nkr46.10 Million | Nkr81.11 Million | Nkr23.71 Million |
| Free Cash Flow | Nkr-10.90 Million | Nkr-1.90 Million | Nkr-31.00 Million | Nkr-78.50 Million | Nkr-74.75 Million |
| Investing Cash Flow | Nkr379.40 Million | Nkr-48.90 Million | Nkr-56.40 Million | Nkr-79.21 Million | Nkr-2.05 Million |
| Financing Cash Flow | Nkr-404.00 Million | Nkr6.70 Million | Nkr52.50 Million | Nkr78.94 Million | Nkr50.16 Million |
| Dividends Paid | Nkr373.20 Million | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Nkr47.80 Million | Nkr50.20 Million | Nkr51.40 Million | Nkr51.08 Million | Nkr48.25 Million |
| Change in Cash | Nkr-12.40 Million | Nkr5.20 Million | Nkr11.20 Million | Nkr454.00K | Nkr-2.93 Million |
Aker Biomarine AS Earnings History — EPS Actual vs. Analyst Estimates
Track Aker Biomarine AS's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 28, 2026 | — | — | — |
| Feb 11, 2026 | — | 0.05 | — |
| Oct 31, 2025 | — | 0.01 | — |
| Jul 11, 2025 | -1.73 | 0.00 | -43260.00% |
| Apr 23, 2025 | -0.39 | -0.02 | -1856.50% |
| Mar 31, 2025 | -0.17 | 0.04 | -525.00% |
| Nov 01, 2024 | 0.09 | 0.03 | +200.00% |
| Jul 12, 2024 | 0.11 | 0.04 | +175.00% |